Version history

{
  "session_id": "sess_SDA-2026-04-15-gap-debate-20260410-112607-0a3749ea_20260416-035130",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "minimax/MiniMax-M2.7",
  "action": "propose",
  "content": "\n\n# Mechanistically Novel Hypotheses: Molecular Signatures of Vulnerability in SEA-AD Data\n\n---\n\n## Hypothesis 1: TREM2-Independent Microglial Lipid Droplet Accumulation Defines Vulnerability Thresholds\n\n**Mechanism**: In vulnerable brain regions, microglia accumulate lipid droplets through impaired cholesterol efflux despite intact TREM2 signaling. This occurs via downregulation of *ABCA1*/*ABCG1* and upregulation of *PLIN2* and *LIPA*, creating a lipid-overloaded state that paradoxically impairs amyloid clearance while promoting pro-inflammatory responses. The CLU/APOE duality may be disrupted when lipid loading saturates APOE's capacity to shuttle cholesterol toward astrocytes for clearance.\n\n**Key Evidence**:\n- Lipid-laden microglia associate with AD pathology (PMID: 30804919)\n- *ABCA1* haploinsufficiency increases AD risk and impairs APOE lipidation (PMID: 17003394)\n\n**Testable Prediction**: If lipid droplet accumulation drives vulnerability, then quantitative proteomics of laser-captured microglia from vulnerable (frontal cortex) vs. resilient (cerebellum) regions should show >2-fold enrichment of PLIN2/LIPA proteins, with correlated reduction in cholesterol ester hydrolase activity, independent of TREM2 genotype effects.\n\n**Target Gene/Protein**: PLIN2 (Perilipin-2)\n\n---\n\n## Hypothesis 2: Astrocyte GLUL Silencing Disrupts Glutamate Cycling Before Amyloid Deposition\n\n**Mechanism**: Vulnerability is defined by early *GLUL* (glutamine synthetase) downregulation in astrocytes, which initiates a feed-forward cycle: impaired glutamate-to-glutamine conversion causes synaptic excitotoxicity, which then triggers *SLC1A2* (EAAT2) downregulation. This astrocyte metabolic failure precedes detectable amyloid and preferentially affects cortical layer V neurons with high metabolic demands.\n\n**Key Evidence**:\n- GLUL activity is reduced in AD hippocampus prior to obvious neuronal loss (PMID: 11438466)\n- EAAT2 dysfunction accelerates excitotoxic neuronal death in AD models (PMID: 16467534)\n\n**Testable Prediction**: If astrocyte glutamate dysfunction defines vulnerability, single-nucleus RNA-seq from pre-symptomatic SEA-AD cases should reveal GLUL+ astrocytes as a distinct cluster with lowered GLUL transcripts in vulnerable regions, while resilient regions maintain normal GLUL expression; this pattern should emerge before amyloid stage 3 pathology.\n\n**Target Gene/Protein**: GLUL (Glutamine Synthetase)\n\n---\n\n## Hypothesis 3: LINGO-1/NogoR1 Signaling Blocks Oligodendrocyte Remyelination in Vulnerable White Matter\n\n**Mechanism**: Oligodendrocyte precursor cells (OPCs) in vulnerable white matter tracts exhibit failed differentiation through *LINGO-1* upregulation, which signals through *RTN4R* (Nogo receptor) to activate *RhoA/ROCK* signaling and maintain OPCs in a proliferative, non-differentiated state. Combined with CLU deficiency reducing APOE-mediated oligodendrocyte support, this creates a \"myelin maintenance failure\" signature distinct from pure amyloid vulnerability.\n\n**Key Evidence**:\n- LINGO-1 antagonists promote remyelination in MS models (PMID: 15009656)\n- *LINGO1* polymorphisms modify AD risk (PMID: 23335882)\n\n**Testable Prediction**: If failed OPC differentiation drives vulnerability, spatial transcriptomics",
  "tokens_used": "816"
}